These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23432646)

  • 1. Emerging insights into the ependymoma epigenome.
    Mack SC; Witt H; Wang X; Milde T; Yao Y; Bertrand KC; Korshunov A; Pfister SM; Taylor MD
    Brain Pathol; 2013 Mar; 23(2):206-9. PubMed ID: 23432646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic and epigenetic basis of ependymoma.
    Mack SC; Taylor MD
    Childs Nerv Syst; 2009 Oct; 25(10):1195-201. PubMed ID: 19536551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic genome-wide analysis identifies BEX1 as a candidate tumour suppressor gene in paediatric intracranial ependymoma.
    Karakoula K; Jacques TS; Phipps KP; Harkness W; Thompson D; Harding BN; Darling JL; Warr TJ
    Cancer Lett; 2014 Apr; 346(1):34-44. PubMed ID: 24333734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ependymoma relapse goes along with a relatively stable epigenome, but a severely altered tumor morphology.
    Yang D; Holsten T; Börnigen D; Frank S; Mawrin C; Glatzel M; Schüller U
    Brain Pathol; 2021 Jan; 31(1):33-44. PubMed ID: 32633004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of ependymoma.
    Yao Y; Mack SC; Taylor MD
    Chin J Cancer; 2011 Oct; 30(10):669-81. PubMed ID: 21959044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighing ependymoma as an epigenetic disease.
    Stuckert A; Bertrand KC; Wang P; Smith A; Mack SC
    J Neurooncol; 2020 Oct; 150(1):57-61. PubMed ID: 32964355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epigenetics of brain tumors.
    Dubuc AM; Mack S; Unterberger A; Northcott PA; Taylor MD
    Methods Mol Biol; 2012; 863():139-53. PubMed ID: 22359291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.
    Rogers HA; Kilday JP; Mayne C; Ward J; Adamowicz-Brice M; Schwalbe EC; Clifford SC; Coyle B; Grundy RG
    Acta Neuropathol; 2012 May; 123(5):711-25. PubMed ID: 22109108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Into Thin Air: Hypoxia Drives Metabolic and Epigenomic Deregulation of Lethal Pediatric Ependymoma.
    Englinger B; Hack OA; Filbin MG
    Dev Cell; 2020 Jul; 54(2):134-136. PubMed ID: 32693052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of histopathological ependymoma variants.
    Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
    Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYCN amplification drives an aggressive form of spinal ependymoma.
    Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
    Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.
    Modena P; Lualdi E; Facchinetti F; Veltman J; Reid JF; Minardi S; Janssen I; Giangaspero F; Forni M; Finocchiaro G; Genitori L; Giordano F; Riccardi R; Schoenmakers EF; Massimino M; Sozzi G
    J Clin Oncol; 2006 Nov; 24(33):5223-33. PubMed ID: 17114655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics and epigenetics: A study of ependymomas in pediatric patients.
    Pérez-Ramírez M; Hernández-Jiménez AJ; Guerrero-Guerrero A; Benadón-Darszon E; Pérezpeña-Díazconti M; Siordia-Reyes AG; García-Méndez A; de León FC; Salamanca-Gómez FA; García-Hernández N
    Clin Neurol Neurosurg; 2016 May; 144():53-8. PubMed ID: 26971296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.
    Milde T; Pfister S; Korshunov A; Deubzer HE; Oehme I; Ernst A; Starzinski-Powitz A; Seitz A; Lichter P; von Deimling A; Witt O
    Genes Chromosomes Cancer; 2009 Mar; 48(3):229-38. PubMed ID: 19025795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profiling in pediatric brain tumors.
    Lau CC
    Cancer J; 2005; 11(4):283-93. PubMed ID: 16197718
    [No Abstract]   [Full Text] [Related]  

  • 16. Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma.
    Hamilton DW; Lusher ME; Lindsey JC; Ellison DW; Clifford SC
    Cancer Lett; 2005 Sep; 227(1):75-81. PubMed ID: 16051033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic analysis of Alu repeats in human ependymomas.
    Xie H; Wang M; Bonaldo Mde F; Rajaram V; Stellpflug W; Smith C; Arndt K; Goldman S; Tomita T; Soares MB
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6952-7. PubMed ID: 20351280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an
    Mangum R; Reuther J; Bertrand KC; Chandramohan R; Kukreja MK; Paulino AC; Muzny D; Hu J; Gibbs RA; Curry DJ; Malbari F; Chintagumpala MM; Adesina AM; Fisher KE; Mack SC; Plon SE; Roy A; Parsons DW; Lin FY
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34651095
    [No Abstract]   [Full Text] [Related]  

  • 19. Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours.
    Lindsey JC; Lusher ME; Strathdee G; Brown R; Gilbertson RJ; Bailey S; Ellison DW; Clifford SC
    Int J Cancer; 2006 Jan; 118(2):346-52. PubMed ID: 16049974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TET2 promotor methylation and TET2 protein expression in pediatric posterior fossa ependymoma.
    Pierscianek D; Teuber-Hanselmann S; Ahmadipour Y; Darkwah Oppong M; Unteroberdörster M; Müller O; Jabbarli R; Sure U; Zhu Y; El Hindy N
    Neuropathology; 2020 Apr; 40(2):138-143. PubMed ID: 31777116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.